Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Paul C. Hendrie"'
Autor:
Mary-Elizabeth M. Percival, Megan Othus, Sarah Mirahsani, Kelda M. Gardner, Carole Shaw, Anna B. Halpern, Pamela S. Becker, Paul C. Hendrie, Mohamed L. Sorror, Roland B. Walter, Elihu H. Estey
Publikováno v:
Haematologica, Vol 106, Iss 8 (2020)
Few patients with cancer, including those with acute myeloid leukemia and high-grade myeloid neoplasms, participate in clinical trials. Broadening standard eligibility criteria may increase clinical trial participation. In this retrospective single-c
Externí odkaz:
https://doaj.org/article/0395b57df88646eda61744ee5d03ecfc
Autor:
Anna B. Halpern, Megan Othus, Emily M. Huebner, Bart L. Scott, Paul C. Hendrie, Mary-Elizabeth M. Percival, Pamela S. Becker, Heather A. Smith, Vivian G. Oehler, Johnnie J. Orozco, Ryan D. Cassaday, Kelda M. Gardner, Tara L. Chen, Sarah A. Buckley, Kaysey F. Orlowski, Asma Anwar, Elihu H. Estey, Roland B. Walter
Publikováno v:
Haematologica, Vol 104, Iss 4 (2019)
Externí odkaz:
https://doaj.org/article/f4c60eaa187e447a9c5cf66831e4bbbf
Autor:
Roland B. Walter, Megan Othus, Kaysey F. Orlowski, Emily N. McDaniel, Bart L. Scott, Pamela S. Becker, Mary-Elizabeth M. Percival, Paul C. Hendrie, Bruno C. Medeiros, Michael T. Chiarella, Arthur C. Louie, Elihu H. Estey
Publikováno v:
Haematologica, Vol 103, Iss 3 (2018)
Externí odkaz:
https://doaj.org/article/b050983645dc49d4893f684b474b0d2c
Autor:
Wei-Gang Tong, Vicky K. Sandhu, Brent L. Wood, Paul C. Hendrie, Pamela S. Becker, John M. Pagel, Roland B. Walter, Elihu H. Estey
Publikováno v:
Haematologica, Vol 100, Iss 3 (2015)
Externí odkaz:
https://doaj.org/article/3227802721044e28a4b8006c7a580e8a
Autor:
Roland B. Walter, Bruno C. Medeiros, Kelda M. Gardner, Kaysey F. Orlowski, Leonel Gallegos, Bart L. Scott, Paul C. Hendrie, Elihu H. Estey
Publikováno v:
Haematologica, Vol 99, Iss 1 (2014)
Epigenetic therapeutics such as the histone deacetylase inhibitor, vorinostat, and the DNA methyltransferase I inhibitor, azacitidine, enhance gemtuzumab ozogamicin efficacy in vitro. We therefore investigated vorinostat/azacitidine/gemtuzumab ozogam
Externí odkaz:
https://doaj.org/article/a48e037ac1f5450fa9441987e9993b83
Autor:
Ryan D. Cassaday, Lucas C. Zarling, Kelsey-Leigh A. Garcia, Olga Sala-Torra, Philip A. Stevenson, Christen H. Martino, Yajuan J. Liu, Min Fang, Mary-Elizabeth M. Percival, Anna B. Halpern, Pamela S. Becker, Vivian G. Oehler, Andrei R. Shustov, Jason P. Cooper, Johnnie J. Orozco, Paul C. Hendrie, Roland B. Walter, Jerald P. Radich, Lorinda A. Soma, Elihu H. Estey
Publikováno v:
Leukemia & Lymphoma. :1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22e372ead163c6b01fa18fbdbac6fc6b
https://doi.org/10.1080/10428194.2023.2189803
https://doi.org/10.1080/10428194.2023.2189803
Autor:
Michelle Y. Zhang, Megan Othus, Carole Shaw, Kelda G. Schonhoff, Anna B. Halpern, Jacob Appelbaum, Paul C. Hendrie, Roland B. Walter, Elihu H. Estey, Mary-Elizabeth M. Percival
Publikováno v:
Leukemia & Lymphoma. :1-7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0332ec2ef154cf42f163058d8245c81f
https://doi.org/10.1080/10428194.2023.2186732
https://doi.org/10.1080/10428194.2023.2186732
Publikováno v:
Annals of Hematology. 102:1613-1615
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0801606cd1c33fe57abef9fa446be09a
https://doi.org/10.1007/s00277-023-05195-5
https://doi.org/10.1007/s00277-023-05195-5
Autor:
Miranda C. Lahman, Thomas M. Schmitt, Kelly G. Paulson, Nathalie Vigneron, Denise Buenrostro, Felecia D. Wagener, Valentin Voillet, Lauren Martin, Raphael Gottardo, Jason Bielas, Julie M. McElrath, Derek L. Stirewalt, Era L. Pogosova-Agadjanyan, Cecilia C. Yeung, Robert H. Pierce, Daniel N. Egan, Merav Bar, Paul C. Hendrie, Sinéad Kinsella, Aesha Vakil, Jonah Butler, Mary Chaffee, Jonathan Linton, Megan S. McAfee, Daniel S. Hunter, Marie Bleakley, Anthony Rongvaux, Benoit J. Van den Eynde, Aude G. Chapuis, Philip D. Greenberg
Publikováno v:
Sci Transl Med
Science translational medicine, Vol. 14, no.631, p. eabg8070 (2022)
Science translational medicine, Vol. 14, no.631, p. eabg8070 (2022)
Designing effective antileukemic immunotherapy will require understanding mechanisms underlying tumor control or resistance. Here, we report a mechanism of escape from immunologic targeting in an acute myeloid leukemia (AML) patient, who relapsed 1 y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23ab8910054866ad4b7f3c2247308f44
https://doi.org/10.1126/scitranslmed.abg8070
https://doi.org/10.1126/scitranslmed.abg8070
Autor:
Noam E. Kopmar, Ted Gooley, Niall Curley, Kathryn Russell, Carole Shaw, Kelda Schonhoff, John Lim, Anna B. Halpern, Roland B. Walter, Bart L. Scott, Jacob Appelbaum, Paul C. Hendrie, Elihu H. Estey, Mary-Elizabeth M. Percival
Publikováno v:
Leukemia & Lymphoma. :1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::558049d9b65bf08addd097a1b15c395d
https://doi.org/10.1080/10428194.2023.2185087
https://doi.org/10.1080/10428194.2023.2185087